Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Opicapone for the management of end-of-dose motor fluctuations in patients with Parkinson's disease treated with L-DOPA

Lees AJ, Ferreira J, Rascol O, Reichmann H, Stocchi F, Tolosa E, Poewe W.

Expert Rev Neurother. 2017 Jul;17(7):649-659. doi: 10.1080/14737175.2017.1336086. Epub 2017 Jun 5.

Global, Yet Incomplete Overview of Cohort Studies in Parkinson's disease

Heinzel S, Lerche S, Maetzler W, Berg D.

J Parkinsons Dis. 2017;7(3):423-432. doi: 10.3233/JPD-171100.

Cognitive Training and Noninvasive Brain Stimulation for Cognition in Parkinson's Disease: A Meta-analysis

Lawrence BJ, Gasson N, Bucks RS, Troeung L, Loftus AM.

Neurorehabil Neural Repair. 2017 Jul;31(7):597-608. doi: 10.1177/1545968317712468. Epub 2017 Jun 5.

The impact of obesity on neurodegenerative diseases

Mazon JN, de Mello AH, Ferreira GK, Rezin GT.

Life Sci. 2017 Aug 1;182:22-28. doi: 10.1016/j.lfs.2017.06.002. Epub 2017 Jun 3.

Modeling Parkinson's disease with induced pluripotent stem cells harboring α-synuclein mutations

Singh Dolt K, Hammachi F, Kunath T.

Brain Pathol. 2017 Jul;27(4):545-551. doi: 10.1111/bpa.12526.

Structural evaluation of an amyloid fibril model using small-angle x-ray scattering

Dahal E, Choi M, Alam N, Bhirde AA, Beaucage SL, Badano A.

Phys Biol. 2017 Jun 29;14(4):046001. doi: 10.1088/1478-3975/aa776a.

Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections

Samotus O, Lee J, Jog M.

PLoS One. 2017 Jun 6;12(6):e0178670. doi: 10.1371/journal.pone.0178670. eCollection 2017.

Aminochrome as preclinical model for Parkinson's disease

Segura-Aguilar J.

Oncotarget. 2017 Jul 11;8(28):45036-45037. doi: 10.18632/oncotarget.18353.

Deep brain stimulation failure due to external cardioversion in a patient with Parkinson's disease

Sobstyl M, Michałowska M, Fiszer U, Ząbek M.

Neurol Neurochir Pol. 2017 Jul-Aug;51(4):324-330. doi: 10.1016/j.pjnns.2017.05.005. Epub 2017 May 30.

Puzzling Out Synaptic Vesicle 2 Family Members Functions

Bartholome O, Van den Ackerveken P, Sánchez Gil J, de la Brassinne Bonardeaux O, Leprince P, Franzen R, Rogister B.

Front Mol Neurosci. 2017 May 22;10:148. doi: 10.3389/fnmol.2017.00148. eCollection 2017.

Metformin - a Future Therapy for Neurodegenerative Diseases : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla

Markowicz-Piasecka M, Sikora J, Szydłowska A, Skupień A, Mikiciuk-Olasik E, Huttunen KM.

Pharm Res. 2017 Dec;34(12):2614-2627. doi: 10.1007/s11095-017-2199-y. Epub 2017 Jun 6.

Adaptive DBS in a Parkinson's patient with chronically implanted DBS: A proof of principle

Piña-Fuentes D, Little S, Oterdoom M, Neal S, Pogosyan A, Tijssen MAJ, van Laar T, Brown P, van Dijk JMC, Beudel M.

Mov Disord. 2017 Aug;32(8):1253-1254. doi: 10.1002/mds.26959. Epub 2017 Jun 7.

Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease

Duce JA, Wong BX, Durham H, Devedjian JC, Smith DP, Devos D.

Mol Neurodegener. 2017 Jun 7;12(1):45. doi: 10.1186/s13024-017-0186-8.

Induced pluripotent stem cell models of lysosomal storage disorders

Borger DK, McMahon B, Roshan Lal T, Serra-Vinardell J, Aflaki E, Sidransky E.

Dis Model Mech. 2017 Jun 1;10(6):691-704. doi: 10.1242/dmm.029009.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias